The evolving nature of public health concerns and continuous improvement of existing vaccination strategies keep VRBPAC active. But VRBPAC also convenes often to hear, discuss, and make recommendations on issues impacting research and the public health. A prime example is the annual discussion on the selection of strains to be included in the influenza virus vaccine for the upcoming influenza season. Another is the VRBPAC's contribution to products targeted against the threats of bioterrorism.
ECG has been helping clients present to VRBPAC for over a decade. We've worked with them to obtain product approvals for multi-valent infant, adolescent, and adult vaccinations as well as to prepare for discussions related to regulatory and development pathways for novel vaccination targets. We are proud of our contributions to hearings related to other major health topics at VRBPAC such as hepatitis A, hepatitis B, and HIV.
Please contact us via email or at +1-201-894-8200 to discuss your needs or to get further information about how we can support your upcoming VRBPAC meeting.